Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

Sector

Healthcare

Industry

Biotechnology

CEO

Sofer, Uzi

Employees

125

Website

www.alphatau.com

IPO Date

2021-03-08

Headquarters

Kiryat HaMada St. 5, Jerusalem 9777605, Israel

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Alpha Tau Medical DRTS

Alpha Tau Medical Earnings Call Summary

Alpha Tau Medical Earnings

Transcripts

Events

About Alpha Tau Medical Ltd.

Alpha Tau Medical
DRTS